Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Nucleic Acid Detection Kit

NCT05492227 is registered in ClinicalTrials.gov with TransGen Biotech Co., LTD as lead sponsor.

NCT NCT05492227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05492227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Nucleic Acid Detection Kit
Lead sponsor
TransGen Biotech Co., LTD
Phase
Observational
Overall status
Completed
Start date
July 5, 2022
Completion date
September 30, 2022
Enrollment
607 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid-19, covid-19 pandemic, diagnoses disease